Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2010
03/04/2010WO2010023725A1 Novel compound signamycin, method for production thereof, and use thereof
03/04/2010WO2010023346A1 Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses
03/04/2010WO2010023341A1 New chitinase of bacterial origin with broad fungicide spectrum
03/04/2010WO2010023247A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies.
03/04/2010WO2010023222A1 Administration unit comprising lactic acid bacteria
03/04/2010WO2010023207A2 Antimicrobial agents
03/04/2010WO2010022634A1 New ethylenediamine derivatives
03/04/2010WO2010022590A1 Method for preparation of meropenem
03/04/2010WO2010009068A3 Cyclohexenyl modulators of chemokine receptor activity
03/04/2010WO2010004231A3 Novel compounds, use thereof as medicaments, and method for the preparation thereof
03/04/2010WO2010000686A3 Composition for topical use comprising quinine
03/04/2010WO2009140676A3 Compositions and methods for inhibition of retroviruses
03/04/2010WO2009136086A3 Method of screening for antitubercular compounds
03/04/2010WO2009135199A3 Vaccine compositions and methods
03/04/2010WO2009109532A9 Use of defensins against tuberculosis
03/04/2010US20100056792 Process for Synthesizing Substituted Isoquinolines
03/04/2010US20100056629 Retrovirus-infection inhibitor
03/04/2010US20100056627 Pharmaceutical compositions of alkyl gallates
03/04/2010US20100056604 Methods for stimulating nervous system regeneration and repair by inhibiting phosphodiesterase type iv
03/04/2010US20100056596 Resistance-repellent retroviral protease inhibitors
03/04/2010US20100056586 Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth
03/04/2010US20100056581 Substituted Piperidino Phenyloxazolidinones
03/04/2010US20100056569 Heterocyclic Non-Nucleoside Compounds, Their Preparation, Pharmaceutical Composition And Their Use As Antiviral Agents
03/04/2010US20100056540 Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
03/04/2010US20100056535 Inhibitors of HIV-1 reverse transcriptase
03/04/2010US20100056531 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
03/04/2010US20100056516 1-hydroxy naphthyridine compounds as anti-hiv agents
03/04/2010US20100056511 2- [ (2-substituted) -ind0lizin-3-yl] -2-oxo-acetamide derivatives as antifungal agents
03/04/2010US20100056506 Substituted 2-amino-fused heterocyclic compounds
03/04/2010US20100056500 Stable Parenteral Formulation
03/04/2010US20100056485 Nanosoap containing silver nanoparticles
03/04/2010US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
03/04/2010US20100056447 Immunization against chlamydia pneumoniae
03/04/2010US20100056443 Radiopharmaceutical to be used in distinction between inflammations and infections in orthopaedic implants
03/04/2010US20100056435 Depsipeptides and Their Therapeutic Use
03/04/2010US20100056432 Template-fixed peptidomimetics with antibacterial activity
03/04/2010US20100056423 Bacterial-Derived BLIS for Treatment of Acne
03/04/2010US20100055202 Antiinfective free intramammary veterinary composition
03/04/2010US20100055158 Environmentally Activated Compositions, Articles and Methods
03/04/2010US20100055157 Silver based antimicrobial compositions and articles
03/04/2010US20100055134 Method of separating protective components of bordetella pertussis
03/04/2010US20100055131 Reovirus compositions and methods of use
03/04/2010US20100055130 Staphylococcus aureus proteins and nucleic acids
03/04/2010US20100055122 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
03/04/2010US20100055111 Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cells
03/04/2010US20100055106 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
03/04/2010US20100055082 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
03/04/2010US20100055071 Anti-Viral Compounds
03/04/2010US20100055069 Hpv-18-based papillomavirus vaccines
03/04/2010DE102008045194A1 Medizinisches Präparat auf pflanzlicher Basis Medical preparation plant-based
03/04/2010CA2736860A1 Methods of treatment using single doses of oritavancin
03/04/2010CA2735439A1 Analysis of hcv genotypes
03/04/2010CA2735421A1 Delivery of a cd40 agonist to a tumor draining lymph node of a subject
03/04/2010CA2735419A1 Compound signamycin, method for producing the same, and use of the same
03/04/2010CA2735164A1 West nile virus vaccine
03/04/2010CA2735077A1 Antimicrobial agents
03/04/2010CA2734390A1 Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
03/04/2010CA2732438A1 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
03/04/2010CA2732215A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies
03/03/2010EP2159229A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same
03/03/2010EP2159225A1 Gemifloxacin process and polymorphs
03/03/2010EP2159224A1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
03/03/2010EP2159220A1 Organic compounds
03/03/2010EP2158916A1 Administration unit comprising lactic acid bacteria
03/03/2010EP2157977A1 Modulation of intestinal flora of hiv patients
03/03/2010EP1910360B1 Hiv reverse transcriptase inhibitors
03/03/2010EP1888580B1 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof
03/03/2010EP1753858B1 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
03/03/2010EP1743648B1 Method for treating inflammation
03/03/2010EP1569656B1 Phosphoantigens for regulating an immune response
03/03/2010EP1519952B1 Use of aspartic proteases in cosmetics and therapeutics
03/03/2010EP1505973B1 Combinations for treating multiple myeloma
03/03/2010EP1401421B1 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
03/03/2010EP1162998B1 Vaccine against streptococcus pneumoniae capsular polysaccharides
03/03/2010EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
03/03/2010CN101659639A Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
03/03/2010CN101658669A Attenuated live vaccine
03/02/2010US7671186 Multimeric hybrid genes encoding the chimeric protein; single recombinant immunogen capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV)
03/02/2010US7671087 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/02/2010US7671086 Pharmaceutical compositions comprising flavonoids and menthol
03/02/2010US7671078 1,3-dicyclohexyl-2-(5,6-dihydro-imidazo[2,1-b]thiazol-3-ylmethyl)-isothiourea; 1,3-dicycloheptyl-2-(6,6-dimethyl-5,6-dihydroimidazo[2,1-b]thiazol-3-ylmethyl)-isothiourea; CXC chemokine Receptor
03/02/2010US7670766 Early detection of flaviviruses using the NS1 glycoprotein
03/02/2010US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab
03/02/2010US7670599 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy
03/02/2010CA2394615C Substituted 1,3,4-oxadiazoles and a method of reducing tnf-.alpha. levels
03/02/2010CA2373833C Medicinal compositions for preventing or treating viral myocarditis
02/2010
02/25/2010WO2010022238A2 Anti-flavivirus therapeutic
02/25/2010WO2010022128A1 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010021930A1 Prevention and treatment of mrsa infections with chitosan-derivatives
02/25/2010WO2010021717A2 Hcv protease inhibitors
02/25/2010WO2010021697A2 Antibodies to ccr2
02/25/2010WO2010021681A2 Compositions and methods for treatment of viral diseases
02/25/2010WO2010021579A1 Anti-infective compounds and uses thereof
02/25/2010WO2010021289A1 Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration
02/25/2010WO2010021129A1 Apoptosis inhibitor
02/25/2010WO2010020694A1 Polynucleotides which down-regulate the expression of the sbi protein
02/25/2010WO2010020676A1 The use of topoisomerase type i inhibitors to treat viral infections
02/25/2010WO2010020136A1 Sterilizing polymer and method of preparation thereof
02/25/2010WO2010020036A1 Siderophore-mediated iron uptake in bacterial infection
1 ... 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 ... 1798